Effect of roflumilast on lung function and exacerbations in patients with chronic obstructive pulmonary disease: Results of a one year study

被引：0
|
作者：
Calverley, PMA
Fabbri, LM
Teichmann, P
Bredenbroeker, D
机构：
[1] Univ Hosp Aintree, Liverpool, Merseyside, England
[2] Univ Modena, I-41100 Modena, Italy
[3] ALTANA Pharma AG, Constance, Germany
来源：
THORAX | 2005年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II42 / II42
页数：1
相关论文
共 50 条
  • [1] Roflumilast improves lung function and quality of life in chronic obstructive pulmonary disease
    Rabe, KF
    O'Donnell, D
    Bateman, ED
    Andrae, K
    Witte, S
    Bredenbrocker, D
    CHEST, 2004, 126 (04) : 709S - 709S
  • [2] Impact of Roflumilast on Exacerbations Among Patients With Chronic Obstructive Pulmonary Disease (COPD) in the Real World
    Wan, Yin
    Shorr, Andrew
    Sun, Shawn
    Corman, Shelby
    Huang, Xingyue
    Gao, Xin
    CHEST, 2013, 144 (04)
  • [3] Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients
    Liu, Dong-yang
    Wang, Zhi-guo
    Gao, Yuan
    Zhang, Hui-min
    Zhang, Yu-xiang
    Wang, Xiao-jun
    Peng, Dan
    MEDICINE, 2018, 97 (07)
  • [4] Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
    Ostrovskyy, Mykola
    Savelikhina, Iryna
    Ostrovska, Kseniia
    Varunkiv, Oleksandr
    Kulynych-Miskiv, Mariana
    Korzh, Galyna
    Shvets, Kostiantyn
    Korzh, Nadiia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
    Alispahic, Imane Achir
    Sorensen, Rikke
    Eklof, Josefin
    Sivapalan, Pradeesh
    Lokke, Anders
    Seersholm, Niels
    Vestergaard, Jakob Hedemark
    Jensen, Jens-Ulrik Staehr
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [6] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EMPHYSEMA
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Dakin, Paula
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Robinson, Lacey
    Abdulai, Raolat
    CHEST, 2024, 166 (04) : 4809A - 4813A
  • [7] Chronic Obstructive Pulmonary Disease Exacerbations and Lung Function Decline Mechanism or Marker?
    Calverley, Peter M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (03) : 278 - 279
  • [8] Roflumilast In Chronic Obstructive Pulmonary Disease
    Sanford, Mark
    DRUGS, 2010, 70 (12) : 1615 - 1627
  • [9] Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study
    Miravitlles, M
    Ferrer, M
    Pont, A
    Zalacain, R
    Alvarez-Sala, JL
    Masa, F
    Verea, H
    Murio, C
    Ros, F
    Vidal, R
    THORAX, 2004, 59 (05) : 387 - 395
  • [10] Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Sanchez-Torill, Fernando
    McIvor, Andrew
    Teichmann, Peter
    Bredenbroeker, Dirk
    Fabbri, Leonardo M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (02) : 154 - 161
12345